Thyroid Cancer Diagnostic Market: By Test Type (Ultrasound, Radioiodine Scan, Computed Tomography Scan, MRI Scan, PET Scan, Blood Tests, Biopsy, Other Tests), By Distribution(Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Thyroid cancer diagnostic market size was valued at 2.5 billion in 2022 and is expected to grow at a CAGR of 5.6% from 2023-2029. Thyroid cancer is a type of cancer that occurs when abnormal cells begin to grow in the thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in the early stage and progresses with the formation of a lump in the thyroid gland. If diagnosed in the early stage it can be treated easily. The thyroid cancer diagnostic market is expected to show significant growth over the forecast period owing to the increasing prevalence of thyroid cancer and technological advancements are expected to boost the thyroid cancer diagnostic market. Imaging tests are mandatory in the diagnosis and confirmation of thyroid cancer, imaging test market is expected to dominate the thyroid cancer diagnostic market over the forecast period. Biopsy is the second most important diagnostic tool in thyroid cancer diagnosis and is expected to grow at a significant rate over the forecast period. The diagnostic imaging sector has shown technological advances in the last few years and is expected to grow in the forecasted period. A positron emission tomography (PET) scan is the latest technology in thyroid cancer diagnosis it takes 3-D color images that are used to determine the spread of cancer.

Thyroid Cancer Diagnostic Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.6%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Thyroid Cancer Diagnostic Market Dynamics

Market for thyroid cancer diagnostics driven by growing incidence of autoimmune diseases such as Grave’s disease and Hashimoto’s thyroiditis. Iodine deficiency is as a prime risk factor for the increase in prevalence of thyroid disorders, increase in incidences of thyroid diagnosis, which is expected to increase drive the market over the forecast period. Innovation and advancement in the testing technology and need for accurate diagnosis of thyroid cancer is also expected to boost the growth in the thyroid cancer diagnosis market.

Key Features of the Reports

  • The thyroid cancer diagnostic market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Thyroid Cancer Diagnostic Market Segmentation

By Type
  • Ultrasound
  • Radioiodine Scan
  • Computed Tomography Scan
  • MRI Scan
  • PET Scan
  • Blood Tests
  • Biopsy
  • Other Tests
By Distribution Channel
  • Hospital Associated Labs
  • Independent Diagnostic Labs
  • Diagnostic Imaging Centers
  • Cancer Research Institutes
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions

The thyroid cancer diagnostic market size was valued at USD 2.5 billion in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary
2. Global Thyroid Cancer Diagnostic Market Introduction 
2.1.Global Thyroid Cancer Diagnostic Market  - Taxonomy
2.2.Global Thyroid Cancer Diagnostic Market  - Definitions
2.2.1.Type
2.2.2.Distribution Channel
2.2.3.Region
3. Global Thyroid Cancer Diagnostic Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Thyroid Cancer Diagnostic Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Thyroid Cancer Diagnostic Market  By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Ultrasound
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Radioiodine Scan
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Computed Tomography Scan
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. MRI Scan
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. PET Scan
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Blood Tests
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Biopsy
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Other Tests
5.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6. Global Thyroid Cancer Diagnostic Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospital Associated Labs
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Independent Diagnostic Labs
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Diagnostic Imaging Centers
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Cancer Research Institutes
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Thyroid Cancer Diagnostic Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Thyroid Cancer Diagnostic Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Ultrasound
8.1.2.Radioiodine Scan
8.1.3.Computed Tomography Scan
8.1.4.MRI Scan
8.1.5.PET Scan
8.1.6.Blood Tests
8.1.7.Biopsy
8.1.8.Other Tests
8.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospital Associated Labs
8.2.2.Independent Diagnostic Labs
8.2.3.Diagnostic Imaging Centers
8.2.4.Cancer Research Institutes
8.2.5.Others
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Thyroid Cancer Diagnostic Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Ultrasound
9.1.2.Radioiodine Scan
9.1.3.Computed Tomography Scan
9.1.4.MRI Scan
9.1.5.PET Scan
9.1.6.Blood Tests
9.1.7.Biopsy
9.1.8.Other Tests
9.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospital Associated Labs
9.2.2.Independent Diagnostic Labs
9.2.3.Diagnostic Imaging Centers
9.2.4.Cancer Research Institutes
9.2.5.Others
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10. Asia Pacific (APAC) Thyroid Cancer Diagnostic Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Ultrasound
10.1.2.Radioiodine Scan
10.1.3.Computed Tomography Scan
10.1.4.MRI Scan
10.1.5.PET Scan
10.1.6.Blood Tests
10.1.7.Biopsy
10.1.8.Other Tests
10.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospital Associated Labs
10.2.2.Independent Diagnostic Labs
10.2.3.Diagnostic Imaging Centers
10.2.4.Cancer Research Institutes
10.2.5.Others
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Thyroid Cancer Diagnostic Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Ultrasound
11.1.2.Radioiodine Scan
11.1.3.Computed Tomography Scan
11.1.4.MRI Scan
11.1.5.PET Scan
11.1.6.Blood Tests
11.1.7.Biopsy
11.1.8.Other Tests
11.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospital Associated Labs
11.2.2.Independent Diagnostic Labs
11.2.3.Diagnostic Imaging Centers
11.2.4.Cancer Research Institutes
11.2.5.Others
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Thyroid Cancer Diagnostic Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Ultrasound
12.1.2.Radioiodine Scan
12.1.3.Computed Tomography Scan
12.1.4.MRI Scan
12.1.5.PET Scan
12.1.6.Blood Tests
12.1.7.Biopsy
12.1.8.Other Tests
12.2.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospital Associated Labs
12.2.2.Independent Diagnostic Labs
12.2.3.Diagnostic Imaging Centers
12.2.4.Cancer Research Institutes
12.2.5.Others
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1. Abbott Laboratories
13.2.2. Hoffmann-La Roche Ltd.
13.2.3. Thermo Fisher Scientific Inc.,
13.2.4. Siemens AG
13.2.5. Bio Rad Laboratories Inc.
13.2.6. GE Healthcare
13.2.7. Illumina, Inc.
13.2.8. Koninklijke Philips N.V.
13.2.9. Toshiba Medical Systems Corporation
14. Research Methodology 
15. Appendix and Abbreviations 
  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.,
  • Siemens AG
  • Bio Rad Laboratories Inc.
  • GE Healthcare
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Toshiba Medical Systems Corporation

Adjacent Markets